Chronic Migraine
Conditions
Brief summary
This study evaluates the effect in chronic migraine patients of daily 20 minute-transcutaneous sub occipital neurostimulation using the occipital Cefaly° device.
Detailed description
Chronic migraine is a disabling neurological condition affecting 0.5-2% of the population. CM is difficult to treat and preventive treatment options are limited. Due to the inefficiency of available and the lack of new preventive anti-migraine drug, neurostimulation methods have raised great interest in recent years. The ONSTIM study showed a reduction in headache frequency in 39% of patients treated with active ONS during 12 weeks, compared to no improvement in the non-effectively stimulated or medically treated groups.
Interventions
DEVICECefaly Kit Arnold
Occipital neurostimulation can have a therapeutic effect in chronic migraine treatment, thus representing a possible therapeutic option in patients that do not respond to any medication.
Sponsors
University of Liege
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* diagnosis of chronic migraine (ICHD III beta 1.3) with or without medication overuse
Exclusion criteria
* other diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Monthly frequency of migraine days | 2 months treatment |
Secondary
| Measure | Time frame |
|---|---|
| Monthly frequency of headache days | 2 months |
| Monthly frequency of total headache days | 2 months |
| Cumulative monthly headache hours | 2 months |
| Monthly acute drug intake | 2 months |
Countries
Belgium
Contacts
Primary ContactAnna Cosseddu, MD
Outcome results
None listed